Phase II study of sequential S-1 and cyclophosphamide therapy in patients with metastatic breast cancer

BACKGROUND: S-1 and cyclophosphamide (CPA) can be given orally, and their combination may have great potential for treating metastatic breast cancer (MBC). A phase I study of sequential S-1 and CPA therapy was conducted in patients with MBC; the recommended doses that were determined for this regime...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanai, Keiko, Fujii, Takaaki, Horiguchi, Jun, Nakazawa, Yuko, Kurozumi, Sasagu, Obayashi, Sayaka, Yajima, Reina, Shirabe, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648287/
https://www.ncbi.nlm.nih.gov/pubmed/33158432
http://dx.doi.org/10.1186/s12885-020-07550-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648287/
https://www.ncbi.nlm.nih.gov/pubmed/33158432
http://dx.doi.org/10.1186/s12885-020-07550-5

Ejemplares similares